126 related articles for article (PubMed ID: 24252699)
1. Immunologic characterization of a novel inactivated nasal mumps virus vaccine adjuvanted with Protollin.
Young KR; Nzula S; Burt DS; Ward BJ
Vaccine; 2014 Jan; 32(2):238-45. PubMed ID: 24252699
[TBL] [Abstract][Full Text] [Related]
2. Adjuvanted inactivated influenza A(H3N2) vaccines induce stronger immunogenicity in mice and confer higher protection in ferrets than unadjuvanted inactivated vaccines.
Ann J; Samant M; Rheaume C; Dumas C; Beaulieu E; Morasse A; Mallett C; Hamelin ME; Papadopoulou B; Boivin G
Vaccine; 2014 Sep; 32(43):5730-9. PubMed ID: 25173481
[TBL] [Abstract][Full Text] [Related]
3. A novel intranasal Protollin-based measles vaccine induces mucosal and systemic neutralizing antibody responses and cell-mediated immunity in mice.
Chabot S; Brewer A; Lowell G; Plante M; Cyr S; Burt DS; Ward BJ
Vaccine; 2005 Feb; 23(11):1374-83. PubMed ID: 15661386
[TBL] [Abstract][Full Text] [Related]
4. Protollin: a novel adjuvant for intranasal vaccines.
Jones T; Cyr S; Allard F; Bellerose N; Lowell GH; Burt DS
Vaccine; 2004 Sep; 22(27-28):3691-7. PubMed ID: 15315848
[TBL] [Abstract][Full Text] [Related]
5. Murine host responses to respiratory syncytial virus (RSV) following intranasal administration of a Protollin-adjuvanted, epitope-enhanced recombinant G protein vaccine.
Huang Y; Cyr SL; Burt DS; Anderson R
J Clin Virol; 2009 Apr; 44(4):287-91. PubMed ID: 19233722
[TBL] [Abstract][Full Text] [Related]
6. Effects of different adjuvants in the context of intramuscular and intranasal routes on humoral and cellular immune responses induced by detergent-split A/H3N2 influenza vaccines in mice.
Baz M; Samant M; Zekki H; Tribout-Jover P; Plante M; Lanteigne AM; Hamelin ME; Mallett C; Papadopoulou B; Boivin G
Clin Vaccine Immunol; 2012 Feb; 19(2):209-18. PubMed ID: 22190392
[TBL] [Abstract][Full Text] [Related]
7. Induction of Local Secretory IgA and Multifunctional CD4⁺ T-helper Cells Following Intranasal Immunization with a H5N1 Whole Inactivated Influenza Virus Vaccine in BALB/c Mice.
Trondsen M; Aqrawi LA; Zhou F; Pedersen G; Trieu MC; Zhou P; Cox RJ
Scand J Immunol; 2015 May; 81(5):305-17. PubMed ID: 25737202
[TBL] [Abstract][Full Text] [Related]
8. Intranasal administration of a flagellin-adjuvanted inactivated influenza vaccine enhances mucosal immune responses to protect mice against lethal infection.
Hong SH; Byun YH; Nguyen CT; Kim SY; Seong BL; Park S; Woo GJ; Yoon Y; Koh JT; Fujihashi K; Rhee JH; Lee SE
Vaccine; 2012 Jan; 30(2):466-74. PubMed ID: 22051136
[TBL] [Abstract][Full Text] [Related]
9. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
[TBL] [Abstract][Full Text] [Related]
10. Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.
de Haan A; Haijema BJ; Voorn P; Meijerhof T; van Roosmalen ML; Leenhouts K
Vaccine; 2012 Jul; 30(32):4884-91. PubMed ID: 22537989
[TBL] [Abstract][Full Text] [Related]
11. Nasal delivery of Protollin-adjuvanted H5N1 vaccine induces enhanced systemic as well as mucosal immunity in mice.
Cao W; Kim JH; Reber AJ; Hoelscher M; Belser JA; Lu X; Katz JM; Gangappa S; Plante M; Burt DS; Sambhara S
Vaccine; 2017 Jun; 35(25):3318-3325. PubMed ID: 28499553
[TBL] [Abstract][Full Text] [Related]
12. Induction of cross-protective immunity against influenza A virus H5N1 by an intranasal vaccine with extracts of mushroom mycelia.
Ichinohe T; Ainai A; Nakamura T; Akiyama Y; Maeyama J; Odagiri T; Tashiro M; Takahashi H; Sawa H; Tamura S; Chiba J; Kurata T; Sata T; Hasegawa H
J Med Virol; 2010 Jan; 82(1):128-37. PubMed ID: 19950232
[TBL] [Abstract][Full Text] [Related]
13. H9N2 influenza whole inactivated virus combined with polyethyleneimine strongly enhances mucosal and systemic immunity after intranasal immunization in mice.
Qin T; Yin Y; Huang L; Yu Q; Yang Q
Clin Vaccine Immunol; 2015 Apr; 22(4):421-9. PubMed ID: 25673304
[TBL] [Abstract][Full Text] [Related]
14. Zymosan enhances the mucosal adjuvant activity of poly(I:C) in a nasal influenza vaccine.
Ainai A; Ichinohe T; Tamura S; Kurata T; Sata T; Tashiro M; Hasegawa H
J Med Virol; 2010 Mar; 82(3):476-84. PubMed ID: 20087927
[TBL] [Abstract][Full Text] [Related]
15. Novel polyvalent live vaccine against varicella-zoster and mumps virus infections.
Matsuura M; Somboonthum P; Murakami K; Ota M; Shoji M; Kawabata K; Mizuguchi H; Gomi Y; Yamanishi K; Mori Y
Microbiol Immunol; 2013 Oct; 57(10):704-14. PubMed ID: 23905963
[TBL] [Abstract][Full Text] [Related]
16. Safety and immunogenicity of an inactivated whole virus Vero cell-derived Ross River virus vaccine: a randomized trial.
Aichinger G; Ehrlich HJ; Aaskov JG; Fritsch S; Thomasser C; Draxler W; Wolzt M; Müller M; Pinl F; Van Damme P; Hens A; Levy J; Portsmouth D; Holzer G; Kistner O; Kreil TR; Barrett PN
Vaccine; 2011 Nov; 29(50):9376-84. PubMed ID: 22001875
[TBL] [Abstract][Full Text] [Related]
17. Killed Bacillus subtilis spores as a mucosal adjuvant for an H5N1 vaccine.
Song M; Hong HA; Huang JM; Colenutt C; Khang DD; Nguyen TV; Park SM; Shim BS; Song HH; Cheon IS; Jang JE; Choi JA; Choi YK; Stadler K; Cutting SM
Vaccine; 2012 May; 30(22):3266-77. PubMed ID: 22446640
[TBL] [Abstract][Full Text] [Related]
18. Induction of mucosal and systemic immunity against respiratory syncytial virus by inactivated virus supplemented with TLR9 and NOD2 ligands.
Shafique M; Wilschut J; de Haan A
Vaccine; 2012 Jan; 30(3):597-606. PubMed ID: 22120195
[TBL] [Abstract][Full Text] [Related]
19. Mucosal immunization with purified flagellin from Salmonella induces systemic and mucosal immune responses in C3H/HeJ mice.
Strindelius L; Filler M; Sjöholm I
Vaccine; 2004 Sep; 22(27-28):3797-808. PubMed ID: 15315861
[TBL] [Abstract][Full Text] [Related]
20. Protection against influenza virus infection by intranasal vaccine with surf clam microparticles (SMP) as an adjuvant.
Ichinohe T; Watanabe I; Tao E; Ito S; Kawaguchi A; Tamura S; Takahashi H; Sawa H; Moriyama M; Chiba J; Komase K; Suzuki Y; Kurata T; Sata T; Hasegawa H
J Med Virol; 2006 Jul; 78(7):954-63. PubMed ID: 16721854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
